SEC 13F Intelligence

Bradley Foster & Sargent Inc/Ct / ABBV

Bradley Foster & Sargent Inc/Ct’s Abbvie Inc Position

Does Bradley Foster & Sargent Inc/Ct own Abbvie Inc (ABBV)? Yes — 223.1K shares worth $49M (+0.75% of its 13F portfolio) as of Q1 2026, down from 228.0K shares the prior filed quarter.

Position Value
$49M
Q1 2026
Shares
223.1K
% of Portfolio
+0.75%
Quarters Held
28
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $15MQ4 ’18Q1 ’19: $12MQ2 ’19: $11MQ3 ’19: $11MQ4 ’19: $13MQ4 ’19Q1 ’20: $12MQ3 ’20: $15MQ4 ’20: $19MQ1 ’21: $21MQ1 ’21Q2 ’21: $24MQ3 ’21: $24MQ1 ’22: $42MQ2 ’22: $39MQ2 ’22Q3 ’22: $35MQ4 ’22: $42MQ1 ’23: $41MQ2 ’23: $35MQ2 ’23Q3 ’23: $35MQ4 ’23: $39MQ1 ’24: $45MQ2 ’24: $42MQ2 ’24Q3 ’24: $47MQ4 ’24: $42MQ1 ’25: $49MQ2 ’25: $43MQ2 ’25Q3 ’25: $54MQ4 ’25: $52MQ1 ’26: $49Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026223.1K$49M+0.75%
Q4 2025228.0K$52M+0.77%
Q3 2025231.2K$54M+0.79%
Q2 2025232.7K$43M+0.68%
Q1 2025232.3K$49M+0.83%
Q4 2024235.3K$42M+0.70%
Q3 2024238.4K$47M+0.79%
Q2 2024244.3K$42M+0.75%
Q1 2024245.5K$45M+0.81%
Q4 2023252.3K$39M+0.76%
Q3 2023257.5K$35M+0.73%
Q2 2023257.5K$35M+0.73%
Q1 2023257.8K$41M+0.98%
Q4 2022260.9K$42M+1.06%
Q3 2022261.1K$35M+0.97%
Q2 2022257.0K$39M+1.01%
Q1 2022258.0K$42M+0.89%
Q3 2021221.7K$24M+0.56%
Q2 2021213.6K$24M+0.56%
Q1 2021195.3K$21M+0.54%
Q4 2020177.2K$19M+0.50%
Q3 2020170.3K$15M+0.44%
Q1 2020152.9K$12M+0.47%
Q4 2019147.9K$13M+0.40%
Q3 2019148.4K$11M+0.38%
Q2 2019156.9K$11M+0.38%
Q1 2019145.5K$12M+0.41%
Q4 2018158.7K$15M+0.59%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bradley Foster & Sargent Inc/Ct’s full portfolio or all institutional holders of ABBV.